{"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.41","statisticalMethod":"t-test, 2 sided"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"4.1","value":"16.6"},{"groupId":"OG001","spread":"5.4","value":"19.6"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"13"}],"units":"Participants"}],"description":"This measure is the mean time to the beginning of three consecutive days where the platelet count is at least 20,000/mm\\^3 (20 x 10\\^9/L) unsupported by a platelet transfusion.","dispersionType":"Standard Deviation","groups":[{"description":"Patient's randomized to the Propranolol arm will be starting 7 days prior to transplant and continuing through 28 days post-transplant. Propranolol will start at 20mg twice daily and will be titrated to 40mg twice daily as tolerated. Both groups will come back to the hospital weekly in order to assess items such as patient's level of anxiety, depression, your adherence, and also to monitor for side effects. The patient's will complete questionnaires during your visit. These will take approximately 15 minutes to complete. This will continue for up to 7 total weeks for patient's on the Propranolol arm.\n\nPropranolol","id":"OG000","title":"Propranolol"},{"description":"Both groups will come back to the hospital weekly in order to assess items such as patient's level of anxiety, depression, your adherence, and also to monitor for side effects. The patient's will complete questionnaires during your visit. These will take approximately 15 minutes to complete. This will continue for 6 total weeks for patient's on the control arm.","id":"OG001","title":"Control Arm"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"4 weeks","title":"Time (Days) to Platelet Engraftment","type":"SECONDARY","unitOfMeasure":"Days"}